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Abstract
Objective Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes (POEMS) syndrome is 
a rare multisystem disease associated with a plasma-cell dyscrasia. Although pachymeningeal involvement has occasionally 
been described, MRI of the central nervous system (CNS) has not yet been extensively investigated.
Methods We retrospectively evaluated CNS MRI in Europe’s largest single-center cohort of POEMS syndrome. Of 77 
patients who have been formally diagnosed with POEMS, 41 had MRI brain and 29 had MRI spine. A control group of 33 
patients with chronic inflammatory demyelinating polyneuropathy (CIDP) was used as this is the major differential diagnosis. 
Of these CIDP patients, 12 underwent both MRI brain and spine, 7 had solely MRI brain and 14 had MRI spine.
Results In 41 POEMS patients with MRI brain, we identified frequent smooth, diffuse meningeal thickening of the cerebral 
convexities and falx (n = 29, 71%), of which 4 had meningeal collections. 17 (41%) had vascular abnormalities including 
white-matter disease, of which 4 had established infarcts. Of 29 patients with MRI spine, 17 (59%) had thickening of the bra-
chial and lumbosacral plexus. Conversely in 19 CIDP patients with MRI brain, none had meningeal thickening (p < 0.0001); 
however, 8 (42%) had vascular abnormalities (p = 0.85). Of 26 patients with MRI spine, 9 (35%) had brachial or lumbosacral 
plexus thickening (p = 0.06).
Conclusions In contrast to CIDP, POEMS patients frequently have pachymeningeal thickening. Vascular abnormalities and 
plexus thickening were also common but not statistically different to CIDP.
Keywords POEMS · Magnetic resonance imaging · Pachymeningitis · Pachymeningeal thickening
Introduction
POEMS (polyneuropathy, organomegaly, endocrinopathy, 
monoclonal plasma cell disorder, skin changes) syndrome 
is a rare and disabling multisystem condition characterised 
by peripheral neuropathy and a monoclonal plasma cell dis-
order [1]. Additional manifestations include papilloedema, 
extravascular volume overload, sclerotic bone lesions and 
thrombocytosis. However, clinical presentations are hetero-
geneous making the diagnosis challenging. To standardise 
the diagnosis, the major and minor diagnostic criteria were 
proposed in 2003 [5] but despite this POEMS remains diag-
nostically elusive. Patients commonly present with only 
a limited number of the criteria and the subtle bone mar-
row abnormalities provide false reassurance regarding the 
plasma cell dyscrasia.
Patients are frequently (~ 60%) misdiagnosed with other 
neuropathies, usually chronic inflammatory demyelinating 
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polyradiculoneuropathy (CIDP), and subsequently receive 
ineffective immunomodulatory medications [8, 9]. CIDP is 
more common and the neuropathy alone can be difficult to 
distinguish. Furthermore, electrical studies reveal conduc-
tion slowing in both, often with no specific features to dis-
criminate one from the other. Relevant biochemical markers 
of POEMS include lambda light chain associated monoclo-
nal gammopathies and VEGF [8]. Although current recom-
mendations advise imaging for bone lesions, no guidance 
exists on imaging the central nervous system (CNS) [10]. 
Identifying disease-specific characteristics through detailed 
phenotyping will assist in improving both the sensitivity 
and specificity of current diagnostic criteria. Although CNS 
abnormalities including pachymeningeal involvement have 
been described in small case series [2, 3, 11], CNS MRI 
has not been extensively investigated. This study systemati-
cally reviews all our CNS-imaged patients with a confirmed 
POEMS diagnosis and compares these findings with a CIDP 
control group. Specifically, we investigated the frequency 
of meningeal thickening and enhancement, explored CNS 




This study was performed at the POEMS Clinic at Uni-
versity College London Hospital, which treats the largest 
reported POEMS cohorts in Europe. 77 patients who have 
attended this clinic from January 2010 to August 2018 have 
been formally diagnosed with POEMS syndrome according 
to the current diagnostic criteria [5]. Serum VEGF, immuno-
globulins, serum-free light chains, bone marrow biopsy and 
nerve condition studies were collected from all patients. 43 
patients underwent lumbar puncture and cerebrospinal fluid 
(CSF) was tested for tuberculosis and viral studies including 
herpes and enterovirus. Symptom duration was calculated as 
the time interval between symptom onset and MRI date. 41 
patients with POEMS (25 male [61.0%], mean age 60 years 
[range 33–79 years]) underwent brain MRI and 29 spine 
MRI. MRI was performed before the diagnosis of POEMS 
was confirmed in 24 of 41 (58.5%) patients (Supplementary 
Table 1). 33 age- and sex-matched patients from the Uni-
versity College London Hospital CIDP database were used 
as controls, with 19 having brain MRI and 26 having spine 
MRI available (Supplementary Table 2).
Neuroradiological assessment
Patients underwent MRI with gadolinium using a 3.0T 
MRI scanner with a 32-channel receive coil. In our insti-
tution, the routine MRI protocol to assess for meningeal 
disease includes both axial and coronal pre- and post-
contrast FLAIR, sagittal T1-weighted images (including 
diffusion weighted) and axial T2-weighted images. FLAIR 
imaging was performed using a fast FLAIR sequence with 
a repetition time/effective echo time/inversion time of 
9000/150/2400 ms. T1-weighted imaging was performed 
using the 2-dimensional spin-echo method (TR, TE: 500, 
8). All imaging sequences were acquired with a slice thick-
ness/interslice gap = 5/1 mm. Meningeal thickness was 
measured at the point of maximal thickness with > 1 mm 
taken as abnormal. To evaluate nerve roots and plexi, spine 
images including coronal gadolinium-enhanced fat-sup-
pressed T1-weighted, coronal short-tau inversion recovery, 
and axial fat-saturated T2-weighted spin-echo sequences 
were obtained. Post-contrast images were obtained after 
intravenous injection of 0.1 mmol/kg gadopentetate dime-
glumine (gadolinium—GAD). Post-contrast FLAIR imag-
ing was performed prior to post-contrast T1-weighted 
imaging in all cases. Images were independently assessed 
by two consultant neuroradiologists (I.D., C.H.), each 
with > 10 years of specialist experience, blinded to the 
diagnosis and scans were acquired over an 11 year period 
(2007–2018). Images were viewed using PACS (Agfa) 
IMPAX 6.5.1 on 3-megapixel BARCO monitors.
No patients had received treatment for POEMS at the 
time of MRI; however, 66% were previously misdiagnosed 
with CIDP and had received intravenous immunoglobulin 
therapy. As neuroradiological findings are not currently 
part of the POEMS diagnostic criteria, MRI was not used 
to contribute to the POEMS diagnosis in any patients. 
Clinical MRI indications varied but MRI was not part of an 
algorithm for the diagnosis of POEMS. Spinal and plexus 
MRI were performed as part of the diagnostic workup for 
demyelinating neuropathies, predominantly CIDP. Brain 
MRI was performed directed at focal CNS symptoms or 
signs, including strokes, to assist in therapeutic antico-
agulation decisions and also for non-specific symptoms 
(headache). Occasionally it had been performed as part 
of a ‘whole neuroaxis’ protocol where even in peripheral 
nerve disorders MRI often gets performed by referring 
teams for ‘limb weakness’ without any obvious CNS signs. 
Due to insufficient repeat MRI scans available, we were 
unable to follow CNS changes over time and in response 
to chemotherapy or stem cell transplantation. After MRI, 
most patients (57%) underwent a contemporaneous lumbar 
puncture for cerebrospinal fluid analysis, although they 
may have had an LP many months or years beforehand 
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from which any residual meningeal change would have 
resolved.
Statistical analysis
Mean, standard deviation and standard error were calculated 
for all variables. Pearson’s correlation coefficient and step-
wise linear regression analysis were used to compare serum 
biomarkers and symptom duration with neuroradiological 
findings. Fisher’s exact test was used to compare findings 
between POEMS and CIDP groups. A p value of < 0.05 was 
considered statistically significant. Analyses were performed 
using STATA version 13.1 (StataCorp LP, Texas).
Ethical and data availability statement
Ethical approval was not required for this fully anonymised 
and retrospective observational (non-experimental) study. 
All anonymised individual participant data in this retrospec-
tive cohort study are available in the Supplementary Table.
Results
At the time of MRI, the mean age was 59.5 years; 61% 
were male and 67% were white British and the mean dis-
ease duration was 35 months. Mean pre-treatment VEGF 
at diagnosis was 3917 pg/mL (range 200–27,310 pg/mL). 
CSF protein was abnormally raised with mean 1.75 g/L 
(range 0.6–4.8 g/L). Neurophysiological data in POEMS 
were broadly homogeneous, with reports of sensory (84%) 
and motor (92%) neuropathy with demyelinating features 
(86%) and secondary axonal loss (75%). All studied patients 
had stable neurological findings at the time of MRI, except 
for one patient with headache and hypertension who had 
radiographic features of posterior reversible encephalopathy 
syndrome. Detailed neuroimaging data are summarised in 
the supplementary table.
Brain MRI
In the POEMS cohort, 29 of 41 patients (70.7%) had hyper-
trophic pachymeningeal involvement. There was diffuse 
dural thickening involving the majority of the cranial con-
vexities in 27 cases with localised thickening identified in 
2 patients; thickening was smooth in all cases (see Fig. 1 
and Supplementary Image Series). T1-weighted images 
revealed the thickened areas to be hypointense compared to 
the subjacent brain parenchyma and gadolinium sequences 
revealed dural enhancement. Maximal dural thickness varied 
with mean 2.1 mm (range 1–5 mm) with the area of maxi-
mal thickness most often being in the frontal region. In four 
cases, prominent meningeal collections were noted involving 
the falx cerebri. In all four cases, the imaging features of 
these collections were consistent with free fluid, with high 
signal on T2, low signal on T1, suppressing on FLAIR and 
non-enhancing on post-gadolinium studies. The abnormality 
was evident in all in the coronal plane images (see Supple-
mentary Image Series). There were no other radiographic 
features of a low-pressure CSF state to explain the pachy-
meningeal involvement, including tonsillar displacement, 
brainstem slumping, venous distension, pituitary gland size 
(mean 3.5 ± 1.4 mm), subdural effusions or reduced CSF 
volume. None of the 19 CIDP patients with MRI brain had 
meningeal thickening (p < 0.0001 vs. POEMS).
White matter abnormalities consistent with small ves-
sel disease were found in 17 of 41 POEMS patients (41%). 
Four of these patients (10%) had established infarcts. Com-
paratively, eight of 19 (42%) CIDP patients had white mat-
ter abnormalities also consistent with small vessel disease 
(p = 0.85 vs. POEMS).
Neither meningeal thickness or vascular abnormalities 
were correlated with VEGF (r = 0.05, p = 0.78; r = 0.02, 
p = 0.89, respectively) or age (r = 0.33, p = 0.06; r = 0.18, 
p = 0.33). Although meningeal thickness was not correlated 
to symptom duration (r = 0.18, p = 0.26), a significant asso-
ciation was identified between vascular abnormalities and 
symptom duration (r = 0.50, p = 0.002).
Spine MRI
17 of 29 POEMS patients (58.6%) with root and plexus 
imaging had thickening and enhancement of nerve roots. 
This involved both the brachial and lumbosacral plexi in 
15 cases and the brachial plexus only in the remaining two 
patients. In four cases, the thickening involved the intradural 
lumbar nerve roots. No spinal cord parenchymal abnormali-
ties were identified. Nine of 26 (34.6%) CIDP patients had 
thickening and enhancement of nerve roots (p = 0.06 vs. 
POEMS), involving the brachial plexus in 7, lumbosacral 
plexus in 1 and both the brachial and lumbosacral plexi in 
the remaining 1 patient.
Discussion
This is the largest MRI assessment of the CNS, meninges 
and plexi in POEMS syndrome to date. Our major finding 
is that asymptomatic pachymeningeal involvement is a very 
common feature in POEMS syndrome being present in 
70.7% of our imaged patients. The pachymeningeal thicken-
ing was asymptomatic and unrelated to disease duration, but 
also had an unusual distribution, especially in the falx cer-
ebri, and was probably related to intrameningeal fluid effu-
sion as illustrated in 4 cases by high field MRI. Other small 
case series (~ 10 patients) have identified pachymeningeal 
 Journal of Neurology
1 3
involvement at similar frequencies to this larger unselected 
cohort [2, 3, 11]. Interestingly, we also found frequent white 
matter abnormalities and evidence of established cerebral 
infarction at much higher rates than previously reported, 
although the prevalence was similar in the CIDP cohort [6]. 
We also demonstrate prevalent thickened and enhancing 
nerve roots of the brachial and lumbosacral plexi making 
distinction from CIDP by MRI difficult.
Cranial pachymeningeal involvement is rare. It can be 
idiopathic or secondary to a broad variety of conditions 
and imaging features have not been found to be specific to 
any aetiology [7]. Established aetiologies include chronic 
inflammatory and infectious disease (for example, sarcoid 
and tuberculosis), meningeal lymphomatosis and intrac-
ranial hypotension (but where leptomeningeal enhance-
ment is more common). In the 57% of cases where lumbar 
puncture was performed, it was undertaken after MRI and 
inflammatory and infectious causes were excluded on CSF 
as well as blood testing. Pachymeningeal histopathologi-
cal assessment in POEMS has previously demonstrated 
the absence of inflammatory changes, without evidence of 
fibrosis or cellular infiltration on histopathology, trigger-
ing the term POEMS-associated pachymeningeal involve-
ment rather than pachymeningitis [2, 3]. Strong co-expres-
sion of VEGF and VEGF2 on the cellular membrane of 
meningothelial cells suggested that VEGF may be directly 
implicated in pachymeningeal pathogenesis [2].
The majority of POEMS patients (~ 60%) are misdiag-
nosed as having CIDP, leading to diagnosis delay, inef-
ficient treatment and worsening mobility. It appears that 
pachymeningeal involvement is a particularly useful find-
ing which distinguishes POEMS syndrome from CIDP. 
Current diagnostic criteria for POEMS syndrome are 
extensive and clinically comprehensive but do not include 
neuroimaging features. We found no imaging features of 
the vascular abnormalities or plexus thickening that dif-
ferentiate POEMS from CIDP and, therefore, make these 
less useful in this instance. To improve diagnostic speed 
and accuracy, the POEMS diagnostic criteria may ben-
efit from the addition of pachymeningeal thickening as a 
minor criterion; however, this requires further validation 
in a prospective and possibly independent analysis with a 
Fig. 1  a Coronal T2w image showing apparent widening of sub-
dural planes over bifrontal convexities. b Coronal post-gadolinium 
T1w equivalent plane image from the same patient demonstrating 
thick enhancing dura in this area. c Post-gadolinium T1w coronal 
image showing two opposing layers of enhancing dura. The central 
non-enhancing area is effusion: the “double falx” appearance. d Post-
gadolinium T1w image demonstrating diffuse enhancement of intrac-
ranial pachymeninges. e Post-gadolinium T1w image demonstrating 
focal enhancement of intracranial pachymeninges. f Coronal FLAIR 
showing moderate degree of small vessel disease. g Post-gadolinium 
T1w image of the cervical spine level C5 showing intradural lep-
tomeningeal enhancement of cervical nerve roots. h Thickened and 
enhancing roots/proximal lumbar plexus on post-gadolinium T1w 
coronal image. For further images and sequences, please see the Sup-
plementary Image Series
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prospectively collected group of haematological disease 
controls (Table 1).
Conclusions
Pachymeningeal thickening is highly prevalent in POEMS 
syndrome and helps distinguish from the major differential 
diagnosis, CIDP. Although both vascular abnormalities and 
thickened enhancing plexi were also observed in POEMS 
syndrome, these were at rates similar to CIDP.
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